The national burden of Leukemia in Italy from 1990 to 2023: results from the Global Burden of Disease Study 2023.

ABSTRACT:

Background

Following the Global Burden of Disease (GBD) Study 2023 estimates, leukemias globally accounted for 573,000 new cases and 341,000 deaths in 2023. This study investigated the global burden of leukemia at level 3 (leukemia) and 4 (acute lymphoid leukemia-ALL, chronic lymphoid leukemia-CLL, acute myeloid leukemia-AML, chronic myeloid leukemia-CML and other leukemia) and its temporal trends from 1990 to 2023, at Italian national level.

Methods

We used the GBD 2023 estimates to describe the leukemia age-standardized incidence (ASIR), mortality (ASMR), and disability-adjusted life years (ASDR) rates in Italy, the related 1990-2023 crude all-ages and age-standardized average annual rates of changes (ARC), as well the age-standardized mortality-to-incidence ratio (ASMIR).

SUBMITTER: GBD 2023 Italian Leukemia Collaborators 

PROVIDER: S-EPMC12572797 | biostudies-literature | 2025 Oct

REPOSITORIES: biostudies-literature